![Fabrizio Giannotta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fabrizio Giannotta
Keine laufenden Positionen mehr
Karriereverlauf von Fabrizio Giannotta
Ehemalige bekannte Positionen von Fabrizio Giannotta
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ProGenosis SA
![]() ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Vorstandsvorsitzender | 29.06.2006 | - |
Gründer | 02.11.2009 | - |
Ausbildung von Fabrizio Giannotta
University of Liege | Doctorate Degree |
Statistik
International
Belgien | 3 |
Operativ
Chief Executive Officer | 1 |
Founder | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
ProGenosis SA
![]() ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Health Technology |
- Börse
- Insiders
- Fabrizio Giannotta
- Erfahrung